According to The Times of India, Somil Mehta, Head of Retail Research at Mirae Asset ShareKhan, has identified four top stocks to buy for August 4, 2026. The recommendations include Honasa Consumer, Gland Pharma, Bata India, and Siemens, each with specific entry points, stop losses, and target prices.
As reported by The Times of India, Honasa Consumer Ltd. remains in a strong uptrend with a well-defined higher top-higher bottom structure on the daily chart. The stock has traded consistently above its 40-day EMA since April 2026, highlighting sustained bullish control and strong trend persistence. The recommendation includes a buy at current market price with stop loss at ₹437 and a target of ₹485-500. The daily momentum indicator has started turning higher from near the zero line, suggesting improving short-term momentum.
According to The Times of India, Gland Pharma Ltd. continues to trend higher while taking support from its 40-day EMA, reflecting a constructive price structure. The recent consolidation near previous highs appears to be shaping into a potential cup-and-handle formation, with the stock now approaching a breakout from the handle portion. The recommendation includes a buy above ₹2586 with stop loss at ₹2494 and a target of ₹2700-2760. The daily momentum indicator remains in bullish mode and has turned higher, signalling improving buying interest.
As reported by The Times of India, Bata India Ltd. has witnessed a strong rebound from the lower band of its rising channel, reaffirming the stock's positive intermediate-term structure. The recent consolidation has taken the shape of a bullish flag pattern, and prices are now attempting a breakout, signalling the potential resumption of the prior uptrend. The recommendation includes a buy at current market price with stop loss at ₹690 and a target of ₹736-752. The stock is trading above its key daily moving averages and is poised to close the week above its 20-week SMA (698), which would restore positive momentum.
According to The Times of India, Siemens Ltd. staged a decisive breakout from a prolonged consolidation zone in April 2026, marking the beginning of a strong upward move. Following this breakout, the stock entered a healthy consolidation phase and the recent price action indicates a breakout above a declining resistance trendline, suggesting the consolidation may be ending. The recommendation includes a buy at current market price with stop loss at ₹3740 and a target of ₹4050-4150. The stock continues to trade above its key daily moving averages with the daily momentum indicator having turned higher and remaining above the zero line.
